Serum Free Light-Chain and Bone Marrow Biopsy in Myeloma

Published on

Topics include: Treatment

A patient poses a question about whether a bone biopsy is the only way to examine whether the cancer is “diminishing” when it’s light-chain only. Dr. Thomas Martin, a myeloma expert from UCSF, talks about the serum-free light-chain test and what this means for   estimating the path of the disease.

View more programs featuring

Produced in association with

Related Programs

MEK Inhibitors for Multiple Myeloma

Dr. Robert Orlowski explains the first protein kinase inhibitor being studied for myeloma, from ASH 2011


Living Well & Longer with Myeloma: Dr. Sagar Lonial Explains

Dr. Sagar Lonial, Associate Professor at Winship Cancer Institute of Emory University and the Director of Translational Research, B-cell malinancy program as well as Associate Director of Hematology Oncology Fellowship Program, talks about the recent changes in the treatment landscape, overall survival and the quality of life for myeloma patients.


Myeloma Testing and Personalized Treatment

In this video from our myeloma town meeting, Dr. Bill Bensinger and Dr. Noopur Raje explain why myeloma is not a one-treatment-fits-all disease. The experts explore research that is currently underway to help better understand each myeloma patient’s individual journey and how this may lead to more personalized treatments in the future.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on December 17, 2013